Phase I combination study of the PARP inhibitor veliparib...

  • Main
  • 2018 / 1
  • Phase I combination study of the PARP inhibitor veliparib...

Phase I combination study of the PARP inhibitor veliparib plus carboplatin and gemcitabine in patients with advanced ovarian cancer and other solid malignancies

Gray, Heidi J., Bell-McGuinn, Katherine, Fleming, Gini F., Cristea, Mihaela, Xiong, Hao, Sullivan, Danielle, Luo, Yan, McKee, Mark D., Munasinghe, Wijith, Martin, Lainie P.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2017.12.029
Date:
January, 2018
File:
PDF, 530 KB
english, 2018
Conversion to is in progress
Conversion to is failed